Package 72205-071-79

{"route": ["ORAL"], "spl_id": "4d8be129-f3cb-49ad-ae5a-a74a50dff689", "openfda": {"nui": ["N0000186106", "N0000020016", "N0000191273", "N0000191278", "N0000182141", "N0000187062"], "upc": ["0372205071797"], "unii": ["H821664NPK"], "rxcui": ["1790122"], "spl_set_id": ["4d8be129-f3cb-49ad-ae5a-a74a50dff689"], "pharm_class_epc": ["Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]"], "pharm_class_moa": ["AMPA Receptor Antagonists [MoA]", "UGT2B7 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "340 mL in 1 BOTTLE (72205-071-79)", "package_ndc": "72205-071-79", "marketing_start_date": "20251215"}], "brand_name": "PERAMPANEL", "product_id": "72205-071_4d8be129-f3cb-49ad-ae5a-a74a50dff689", "dosage_form": "SUSPENSION", "pharm_class": ["AMPA Receptor Antagonists [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]", "UGT1A9 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "72205-071", "dea_schedule": "CIII", "generic_name": "PERAMPANEL", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PERAMPANEL", "active_ingredients": [{"name": "PERAMPANEL", "strength": ".5 mg/mL"}], "application_number": "ANDA218152", "marketing_category": "ANDA", "marketing_start_date": "20250711", "listing_expiration_date": "20261231"}